Downstream Processing Featured Articles

  1. Researchers Discover New Mutations Driving Malignant Melanoma 1/25/2013

    Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.

  2. Saint-Gobain Adds Large Clamps To Pure-Fit® Line 6/28/2012

    New Pure-Fit® TCL accommodates large diameter and thick wall tubing applications. Saint-Gobain Performance Plastics has expanded its line of innovative tube clamps with the introduction of the new Pure-Fit® TCL large tube clamp.

  3. Cangene Announces Closing Of Acquisition Of Late Stage Hemophilia B Product 2/20/2013

    Cangene Corporation (Cangene) today announces the closing of the acquisition of the investigational hemophilia compound IB1001 and certain other assets from Ipsen and Inspiration Biopharmaceuticals, Inc. in connection with Inspiration's bankruptcy proceedings.

  4. COVID-19 Consortium: Competitive Collab On A Plasma-Derived Therapy 12/14/2020

    A host of global biopharma competitors are collaborating under the CoVIg-19 Plasma Alliance to secure enough convalescent plasma to produce an effective COVID-19 therapeutic at global scale. Takeda’s Dr. Thomas R. Kreil will present at the upcoming FDA/Xavier PharmaLink Conference.

  5. FDA Approves First Drug-Eluting Stent To Treat Peripheral Arterial Disease 11/15/2012

    The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).

  6. Researchers Identify Role For Protein Linked To Obesity, Type 2 Diabetes 12/17/2012

    Researchers at UT Southwestern Medical Center have taken another step toward better understanding the metabolic functions of obesity and its connection to type 2 diabetes.

  7. Research Breakthrough Selectively Represses The Immune System 11/19/2012

    In a mouse model of multiple sclerosis (MS), researchers funded by the National Institutes of Health have developed innovative technology to selectively inhibit the part of the immune system responsible for attacking myelin -- the insulating material that encases nerve fibers and facilitates electrical communication between brain cells.

  8. New Objective And McKinley Scientific Announce A Strategic Co-Marketing Collaboration In High-Performance LC-MS 11/27/2012

    McKinley Scientific, LLC and New Objective, Inc. recently announced that they have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for delivery of high-performance LC-MS systems.

  9. High-Flow Sterile Connectors For Single-Use Applications

    Over the past decade, two developments have increased demand for high fl ow-rate connectors: Size advances in single-use bioreactors up to 2000L and the  implementation of single-use downstream.

  10. 3 Factors To Prevent Protein Aggregation For Your Protein Purification Buffer

    Before you purify your first batch of a new protein it is important to know what buffer you might want to use to keep precipitation of proteins to a minimum.